Cargando…
Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Urologia
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747022/ https://www.ncbi.nlm.nih.gov/pubmed/36173411 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.03 |
| _version_ | 1784849497748144128 |
|---|---|
| author | Barros, Rodrigo de Castro |
| author_facet | Barros, Rodrigo de Castro |
| author_sort | Barros, Rodrigo de Castro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9747022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Sociedade Brasileira de Urologia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97470222022-12-16 Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial Barros, Rodrigo de Castro Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2022-11-01 /pmc/articles/PMC9747022/ /pubmed/36173411 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.03 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Update in Urology Barros, Rodrigo de Castro Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title | Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title_full | Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title_fullStr | Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title_full_unstemmed | Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title_short | Editorial Comment: Intra-cavernous injection of BOTOX ® (50 and 100 Units) for treatment of vasculogenic erectile dysfunction: Randomized controlled trial |
| title_sort | editorial comment: intra-cavernous injection of botox ® (50 and 100 units) for treatment of vasculogenic erectile dysfunction: randomized controlled trial |
| topic | Update in Urology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747022/ https://www.ncbi.nlm.nih.gov/pubmed/36173411 http://dx.doi.org/10.1590/S1677-5538.IBJU.2022.06.03 |
| work_keys_str_mv | AT barrosrodrigodecastro editorialcommentintracavernousinjectionofbotox50and100unitsfortreatmentofvasculogenicerectiledysfunctionrandomizedcontrolledtrial |